The history of Sildenafil presents a nuanced case for stakeholders in the drug sector. While initially a phenomenal success, generating vast sums, the intellectual property lapse and the subsequent flood of generic https://adult921942.blogpixi.com/42113759/the-little-copyright-and-pharma-a-risky-bet